Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 3 1

Status

Recruiting 30Active not recruiting 13Completed 4Not yet recruiting 3Withdrawn 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 2Gastrointestinal 1

Conditions

Neuroblastoma 1Neoplasms 1Glioblastoma 1Esophageal Neoplasms 1Advanced Malignancies 1

Interventions

pembrolizumab 28Cisplatin 18Nivolumab 14Cyclophosphamide 14Carboplatin 14Paclitaxel 12Radiotherapy 10Radiation 10Radiotherapy, Intensity-Modulated 9Magnetic Resonance Spectroscopy 9Doxorubicin 9Docetaxel 9Cytarabine 8Bevacizumab 8Radiosurgery 7Leucovorin 7Gemcitabine 7Fluorouracil 7Vincristine 6Prednisone 6Pemetrexed 6Lenalidomide 6Irinotecan 6Etoposide 6Dexamethasone 6venetoclax 5tislelizumab 5fludarabine 5enzalutamide 5atezolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Temozolomide × 30 days × Clear all
NCT04164199 2026-06-03

Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies

BeOne Medicines

Phase 3 Completed
404 enrolled

Advanced Malignancies

NCT04984733 2026-05-18

ELEVATE

University of Southampton

Phase 2 Completed
13 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplasms

NCT04614909 2026-05-14

Study of Pamiparib in Newly Diagnosed and rGBM

St. Joseph's Hospital and Medical Center, Phoenix

Phase EARLY_PHASE1 Completed
50 enrolled
CNS

Glioblastoma

NCT02308527 2026-05-12

BEACON

University of Birmingham

Phase 2 Completed
225 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡